Skip to content

A Non-Inferiority Randomized Controlled Trial and Prospective Cohort Study Comparing Clinical Outcomes of Unilateral Biportal Endoscopic Surgery Utilizing the Interlaminar Approach Versus the Transforaminal Approach in Patients with Lumbar Disc Herniation

Comparison of Inter Lamina Approach versus Trans Foraminal Approach in Unilateral Biportal Endoscopic Surgery for Lumbar Disc Herniation: A Multicenter Non-Inferiority Randomized Controlled Trial and Prospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1030240158
Enrollment
72
Registered
2024-06-13
Start date
2024-06-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar disc herniation Lumbar disc herniation

Interventions

The two-portal endoscopic spine surgery (Unilateral Biportal Endoscopy:UBE) for lumbar disc herniation is a surgical method that is already being performed both domestically (Japan) and internationall
Endoscopy

Sponsors

Segawa Tomohide
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Individuals who meet all of the following criteria are eligible: (1) Those aged 18 to 80 years at the time of consent. (2) Those diagnosed with lumbar disc herniation at a single spinal level, as confirmed by MRI. (3) Those who have received conservative treatment for more than 6 weeks and present with radiculopathy symptoms rated at an NRS of 3 or higher at the time of consent. (4) Those capable of providing written informed consent of their own free will.

Exclusion criteria

Exclusion criteria: The individuals who fall under any of the following categories are not eligible to participate: (1) Those with a history of previous surgery at the same intervertebral level and on the same side (left or right). (2) Those with significantly extruded hernias, as defined by the radiologic classification of migrated disc herniations into zone classification 1 or 4, as reported in 'Percutaneous Endoscopic Lumbar Discectomy for Migrated Disc Herniation: Classification of Disc Migration and Surgical Approaches,' Eur. Spine J., 2007, 16, pp. 431-437). (3) Those with foraminal or far lateral hernias. (4) Those with concurrent lumbar spinal stenosis. (5) Those with lumbar spondylolisthesis of Meyerding grade 2 or more, or with spondylolysis. (6) Those with lumbar scoliosis exhibiting a Cobb angle of 20 degrees or greater. (7) Those with instability at the surgical level, defined as a lumbar functional X-ray in flexion and extension positions showing a slip of 3 mm or more. (8) Those with reduced lower limb strength (Manual Muscle Test (MMT) grade 2 or lower, capable of movement throughout the range of motion when gravity is eliminated). (9) Those with a history of fractures, tumors, or infections in the surgical level. (10) Those who have undergone lumbar spine fusion surgery at any level, not limited to the intended surgical level. (11) Those with a mental illness or a history thereof, who are poorly controlled in their treatment. (12) Those whose distance from the skin to the target intervertebral disc exceeds the effective length of a standard bipolar radiofrequency system. (13) Those who have difficulty understanding Japanese. (14) Those who the research director (or delegate) deems inappropriate as study subjects.

Design outcomes

Primary

MeasureTime frame
Oswestry Disability Index (ODI) score 12 months post-surgery

Secondary

MeasureTime frame
(1) NRS (Numerical Rating Scale) for surgical site pain assessed at 0, 1, 2, 4, 8, 12, and 24 hours post-operation, with an allowable margin of one hour before or after each specified time for evaluation. (2) NRS for back pain at 2 weeks, 3 months, 6 months, and 12 months post-operation. (3) NRS for leg pain and leg pain at 2 weeks, 3 months, 6 months, and 12 months post-operation. (4) ODI (Oswestry Disability Index) scores at 3 and 6 months post-operation. (5) QOL scores (EuroQol-5 Dimensions, Short Form-12) at 3, 6, and 12 months post-operation. (6) Surgical-related outcomes including hospitalization costs, surgical duration, blood loss, and length of postoperative hospital stay. (7) Perioperative complications including dural tear, reoperation due to postoperative hematoma, surgical site infection within one year, Creatine Phosphokinase ratio the day after surgery, and recurrence rate within one year.

Contacts

Public ContactTomohide Segawa

Inanami Spine and Joint Hospital

t-segawa@iwai.com+81-3-3450-1773

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026